Indian Guaifenesin Exporters: Complete Supplier Ranking with Market Share — 278 Manufacturers (2026) — TransData Nexus

Q: Who is the largest guaifenesin buyer importing from India?

GRANULES CONSUMER HEALTH (UNITED STATES) is the largest guaifenesin importer from India with a 21.9% market share and import value of $5.8M.

Q: How many guaifenesin buyers import from India?

There are 278 active guaifenesin buyers importing from India, with a combined import market of $26.7M across 1,050 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top guaifenesin buyers from India?

The top 5 guaifenesin buyers — GRANULES CONSUMER HEALTH, SPIRIT PHARMACEUTICALS LLC, PERRIGO COMPANY, GRANULES USA INC., AGIO RUS LLC — together control 43.1% of total guaifenesin import value from India.

Suresh Sormare

Guaifenesin

India Pharmaceutical Trade Intelligence

$26.7M151 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES69.6%India → IRAQ3.4%

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $18.6M through 335 shipments. This represents a market share of 69.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• GRANULES CONSUMER HEALTH - $5.8M (31.5% of country's total business)

• SPIRIT PHARMACEUTICALS LLC - $2.8M (14.9% of country's total business)

• PERRIGO COMPANY - $1.1M (6.2% of country's total business)

• GRANULES USA INC. - $905.1K (4.9% of country's total business)

• PRODOSE INC. - $751.9K (4.0% of country's total business)

• Rest of United States's importers - $7.2M (38.5% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $55.5K, indicating premium pricing strategy compared to the market average of $25.4K.

United States is a key market for Guaifenesin imports, representing 69.6% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Guaifenesin buyer market intelligence

1Buyer Segment Analysis

The 278 buyers of Guaifenesin imported from India can be categorized into several segments:

1. Distributors: Entities that purchase Guaifenesin in bulk to supply to various retailers, pharmacies, and healthcare providers. Notable examples include GRANULES CONSUMER HEALTH and SPIRIT PHARMACEUTICALS LLC in the United States. These distributors typically place large, recurring orders to maintain a steady supply chain and meet consistent market demand.

2. Contract Manufacturers: Companies that procure Guaifenesin as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or clients. PERRIGO COMPANY in the United States exemplifies this segment. Their purchasing patterns are aligned with production schedules and client demands, often resulting in substantial and periodic orders.

3. Re-exporters: Firms that import Guaifenesin with the primary intent of exporting it to other markets. AGIO RUS LLC in Russia and MAKANS LIMITED in Fiji fall into this category. Their buying behavior is influenced by international market demands and trade agreements, leading to variable order sizes and frequencies.

4. Retail Chains: Large pharmacy chains or healthcare retailers that import Guaifenesin directly to stock their outlets. SHREE HARI INTERNATIONAL LLC in the United States is an example. These buyers often have consistent purchasing patterns to ensure product availability across multiple locations.

5. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems. IBN SINA SCIENTIFIC BUREAU in Iraq represents this segment. Their procurement is typically characterized by large-volume tenders and is influenced by national healthcare policies and budget allocations.

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and optimizing supply chain operations.

Country-Specific Import Regulations

TransData Nexus Guaifenesin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Guaifenesin from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Guaifenesin is manufactured in facilities compliant with FDA regulations. The product must be listed with the FDA, and importers are required to submit prior notice of importation.

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.

2. Iraq:

Regulatory Authority: Iraqi Ministry of Health.

Demand Drivers & Market Opportunity

TransData Nexus Guaifenesin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Guaifenesin in importing countries is influenced by several factors:

1. Disease Prevalence: Guaifenesin is commonly used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. The prevalence of these conditions has been rising globally. For instance, a study published in 2024 highlighted limited availability and affordability of essential medications for asthma and COPD in low- and middle-income countries, underscoring the need for increased access to treatments like Guaifenesin.

2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their UHC programs, increasing access to essential medicines. The World Health Organization (WHO) emphasizes the importance of essential medicines in achieving UHC, indicating a growing market for such products. (who.int)

3. WHO Essential Medicines List (EML) Procurement: The inclusion of medicines in the WHO EML influences national procurement decisions. While Guaifenesin is not listed in the 23rd WHO EML published in 2023, its therapeutic category is recognized, suggesting potential for inclusion in national EMLs. (who.int)

4. Tender-Based Purchasing: Government and large healthcare organizations often procure medicines through tenders, ensuring bulk purchasing and consistent demand. The presence of 278 buyers across 77 countries indicates a diverse and widespread market, with opportunities for suppliers to engage in tender processes to secure large-volume contracts.

These factors collectively contribute to a robust demand for Guaifenesin, presenting significant market opportunities for suppliers, especially in regions with increasing respiratory disease prevalence and expanding healthcare coverage.

Common Questions — Guaifenesin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest guaifenesin buyer importing from India?

Based on import volume and value, GRANULES CONSUMER HEALTH (UNITED STATES) leads with $5.8M in imports and a 21.9% market share — the highest of any single guaifenesin importer. SPIRIT PHARMACEUTICALS LLC (UNITED STATES) and PERRIGO COMPANY (UNITED STATES) are the next largest buyers.

QHow many companies buy guaifenesin from India?

There are 278 active guaifenesin buyers importing from India, with a combined market of $26.7M across 1,050 shipments to 77 countries. The top 5 buyers hold 43.1% of total import value, while the remaining 273 buyers handle the other 56.9%.

QWhich countries import the most guaifenesin from India?

The top importing countries for guaifenesin from India are United States (69.6%), Iraq (3.4%), Russia (3.2%), Fiji (2.6%), United Arab Emirates (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of guaifenesin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Guaifenesin buyer market intelligence

1Buyer Segment Analysis

The 278 buyers of Guaifenesin imported from India can be categorized into several segments:

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and optimizing supply chain operations.

Country-Specific Import Regulations

TransData Nexus Guaifenesin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Guaifenesin from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.

2. Iraq:

Regulatory Authority: Iraqi Ministry of Health.

Demand Drivers & Market Opportunity

TransData Nexus Guaifenesin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Guaifenesin in importing countries is influenced by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Guaifenesin

Guaifenesin

Who Buys Guaifenesin from India — 278 Importers Behind a $26.7M Market

Top Guaifenesin Importers — Ranked by Import Value

Top Guaifenesin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Guaifenesin — and from which countries?

Guaifenesin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Guaifenesin Buyers & Importers

QWho is the largest guaifenesin buyer importing from India?

QHow many companies buy guaifenesin from India?

QWhich countries import the most guaifenesin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Iraq

3Russia

4Fiji

5United Arab Emirates

QWhat is the average import order value for guaifenesin from India?

Analysis Methodology